XML 31 R19.htm IDEA: XBRL DOCUMENT v3.19.2
Commodity and Other Repurchase Agreements and Collateralized Transactions (Notes)
9 Months Ended
Jun. 30, 2019
Commodity and Other Repurchase Agreements [Abstract]  
Commodity and Other Repurchase Agreements and Collateralized Transactions
Securities and Commodity Financing Transactions
The Company’s outstanding notes receivable in connection with repurchase agreements for agricultural and energy commodities, whereby the clients sell to the Company certain commodity inventory and agree to repurchase the commodity inventory at a future date at a fixed price were $1.3 million and $1.9 million as of June 30, 2019 and September 30, 2018, respectively.
The Company enters into securities purchased under agreements to resell, securities sold under agreements to repurchase, securities borrowed and securities loaned transactions to, among other things, finance financial instruments, acquire securities to cover short positions, acquire securities for settlement, and to accommodate counterparties’ needs. These agreements are recorded as collateralized financings at their contractual amounts plus accrued interest. The related interest is recorded in the condensed consolidated income statements as interest income or interest expense, as applicable. In connection with these agreements and transactions, it is the policy of the Company to receive or pledge cash or securities to adequately collateralize such agreements and transactions in accordance with general industry guidelines and practices. The value of the collateral is valued daily and the Company may require counterparties to deposit additional collateral or return collateral pledged, when appropriate. The carrying amounts of these agreements and transactions approximate fair value due to their short-term nature and the level of collateralization.
The Company pledges financial instruments owned to collateralize repurchase agreements. At June 30, 2019 and September 30, 2018, financial instruments owned, at fair value of $370.9 million and $123.0 million, respectively, were pledged as collateral under repurchase agreements. The counterparty has the right to sell or repledge the collateral in connection with these transactions. These financial instruments owned have been pledged as collateral and have been parenthetically disclosed on the condensed consolidated balance sheet.
In addition, as of June 30, 2019 and September 30, 2018, the Company pledged financial instruments owned, at fair value of $1,450.8 million and $1,481.1 million, respectively, and repledged securities received under reverse repurchase agreements of $1,134.5 million and $369.8 million, respectively, to meet collateral requirements for tri-party repurchase agreements. For these securities, the counterparties do not have the right to sell or repledge the collateral and, therefore, they have not been parenthetically disclosed on the condensed consolidated balance sheet.
The Company also has repledged securities borrowed and client securities held under custodial clearing arrangements to collateralize securities loaned agreements with a fair value of $1,213.3 million and $267.9 million as of June 30, 2019, and September 30, 2018, respectively. Additionally, the Company has also pledged financial instruments owned with a fair value of $18.9 million and $27.1 million as of June 30, 2019, and September 30, 2018, respectively, to collateralize uncommitted loan facilities with certain banks as discussed further in Note 10.
At June 30, 2019 and September 30, 2018, the Company had accepted collateral that it is permitted by contract to sell or repledge. This collateral consists primarily of securities received in reverse repurchase agreements, securities borrowed agreements, and margin securities held on behalf of correspondent brokers. The fair value of such collateral at June 30, 2019 and September 30, 2018, was $2,904.8 and $1,294.8 million, respectively, of which $427.1 million and $473.9 million, respectively, was used to cover securities sold short which are recorded in financial instruments sold, not yet purchased on the condensed consolidated balance sheet. In the normal course of business, this collateral is used by the Company to cover financial instruments sold, not yet purchased, to obtain financing in the form of repurchase agreements or bank loans, and to meet counterparties’ needs under lending arrangements.
The following tables provide the contractual maturities of gross obligations under repurchase and securities lending agreements as of June 30, 2019 and September 30, 2018 (in millions):
 
June 30, 2019
 
Overnight and Open
 
Less than 30 Days
 
30-90 Days
 
 
Total
Securities sold under agreements to repurchase
$
1,816.4

 
$
585.3

 
$
499.0

 
 
$
2,900.7

Securities loaned
1,240.9

 

 

 
 
1,240.9

Gross amount of secured financing
$
3,057.3

 
$
585.3

 
$
499.0

 
 
$
4,141.6

 
September 30, 2018
 
Overnight and Open
 
Less than 30 Days
 
30-90 Days
 
 
Total
Securities sold under agreements to repurchase
$
934.9

 
$
661.3

 
$
340.5

 
 
$
1,936.7

Securities loaned
277.9

 

 

 
 
277.9

Gross amount of secured financing
$
1,212.8

 
$
661.3

 
$
340.5

 
 
$
2,214.6


The following table provides the underlying collateral types of the gross obligations under repurchase and securities lending agreements as of June 30, 2019 and September 30, 2018 (in millions):
Securities sold under agreements to repurchase
June 30, 2019
 
September 30, 2018
U.S. Treasury obligations
$
57.1

 
$
39.6

U.S. government agency obligations
259.8

 
461.7

Asset-backed obligations
94.5

 
50.0

Agency mortgage-backed obligations
2,489.3

 
1,385.4

Total securities sold under agreement to repurchase
2,900.7

 
1,936.7

 
 
 
 
Securities loaned
 
 
 
Equity securities
1,240.9

 
277.9

Total securities loaned
1,240.9

 
277.9

Gross amount of secured financing
$
4,141.6

 
$
2,214.6